Aclidinium bromide for the treatment of chronic obstructive pulmonary disease

@article{Cazzola2013AclidiniumBF,
  title={Aclidinium bromide for the treatment of chronic obstructive pulmonary disease},
  author={M. Cazzola and C. Page and M. G. Matera},
  journal={Expert Opinion on Pharmacotherapy},
  year={2013},
  volume={14},
  pages={1205 - 1214}
}
  • M. Cazzola, C. Page, M. G. Matera
  • Published 2013
  • Medicine
  • Expert Opinion on Pharmacotherapy
  • Introduction: Although there are some challenges with current therapies, the growing evidence that tiotropium bromide is important in the maintenance treatment of chronic obstructive pulmonary disease (COPD) has led to enthusiastic investigation in search of novel muscarinic antagonists which share some of the beneficial characteristics of tiotropium and perhaps improve upon less desirable ones. Areas covered: Aclidinium bromide is a new muscarinic antagonist that has been developed to relieve… CONTINUE READING

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 60 REFERENCES
    Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease
    • 77
    • Highly Influential
    • PDF
    Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study
    • 175
    • Highly Influential
    • PDF
    Novel bronchodilators for the treatment of chronic obstructive pulmonary disease.
    • 77
    Aclidinium bromide provides long-acting bronchodilation in patients with COPD.
    • 57
    • PDF
    Pharmacology and Therapeutics of Bronchodilators
    • 326
    • PDF